Skip to content

News Releases

 
News Releases
  Date Title and Summary View
Sep 21, 2018
TITUSVILLE, N.J., Sept. 21, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from a Phase 3 clinical study of the investigational product esketamine nasal spray in patients with treatment-resistant depression. Janssen researchers presented these results at the Ninth Biennial Conference of the In...
Sep 19, 2018
NEW BRUNSWICK, N.J., Sept. 19, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 16th, to review third-quarter results.  Joseph J. Wolk, Executive Vice President, Chief Financial Officer and Christopher DelOrefice, Vice President, Investor Relations will host...
Sep 18, 2018
Sep 11, 2018
Sep 4, 2018
TITUSVILLE, N.J., Sept. 4, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for esketamine nasal spray. Janssen is seeking FDA approval of esketamine for treatment-resistant depression in adults. ...
Aug 27, 2018
NEW BRUNSWICK, N.J., Aug. 27, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 2018 Morgan Stanley 16th Annual Global Healthcare Conference on Friday, September 14th, at The Grand Hyatt Hotel in New York.  Alex Gorsky, Chairman and Chief Executive Officer will represent the Company in a session scheduled at 9:55 a.m. (East...
Aug 27, 2018
Aug 27, 2018
Aug 27, 2018
NEW BRUNSWICK, N.J., Aug. 27, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:00 a.m. (Eastern Time) on Monday, August 27th, to review the Phase 3 MARINER and COMMANDER HF studies for XARELTO® presented at the European Society of Cardiology Congress 2018.  James List, M.D., Ph.D., Global Therapeutic...
Aug 20, 2018
NEW BRUNSWICK, N.J., Aug. 20, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:00 a.m. (Eastern Time) on Thursday, September 13th, to review its Pharmaceutical Business.   Joaquin Duato, Vice Chairman of the Executive Committee; Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmace...
Page:
1
... NextLast
= add release to Briefcase